Article

Overdose Risk After Abstinence: Why Tolerance Falls and Why Aftercare Matters

← Back to blog

Published

Headshot of Danesh Alam MD, DFAPA, DFASAM

Medically reviewed by Danesh Alam MD, DFAPA, DFASAM

A naloxone nasal-spray kit on a table, used to illustrate overdose risk after abstinence and the need to keep naloxone on hand.
Photo for illustrative purposes. Photo: SeventyFour / Shutterstock.

Overdose risk after abstinence is higher because opioid tolerance falls when someone has not been using. A dose that used to feel familiar can now slow or stop breathing. This is not a moral failing, and it is not rare. It is a predictable change in the body, made more dangerous by illicit fentanyl, by mixing opioids with alcohol or benzodiazepines, and by using alone.

If someone cannot be woken or is not breathing normally, call 911 now and give naloxone if you have it. Stay with the person until help arrives.

This article explains why tolerance drops, when the risk is highest, what local overdose data show in Palm Beach County, and what actually reduces risk after detox or a residential stay. It is not a guide to using more safely as a substitute for treatment, and it is not a rewrite of our earlier explainer on xylazine and nitazenes in the drug supply.

What opioid tolerance is, and why it falls

Tolerance means the body has adapted to a substance, so the same amount produces a weaker effect than it once did. People who have used opioids regularly often need more of the drug to get the effect they used to get at a lower dose. When use stops — during detox, a residential stay, incarceration, or any other period of abstinence — that adaptation can recede. The person may feel as if they have "reset." The danger is that a return to a previous dose is no longer a return to a previous level of safety.

The Centers for Disease Control and Prevention (CDC) lists returning to a high dose after losing tolerance as an overdose risk factor. The examples the CDC gives include tapering and recent release from prison. CDC: Risks and how to reduce them

The National Institute on Drug Abuse (NIDA) makes the same point for clinicians treating opioid use disorder: overdose risk factors include "having a lowered tolerance, such as when a person has been abstinent during active treatment for opioid use disorder, or after incarceration." NIDA: Overdose prevention education for clinicians

How many days it takes for any one person's tolerance to fall is not a number this article will invent. The practical message from those federal sources is simpler: after a period without opioids, do not assume that a dose you used before is still survivable.

Why overdose risk after abstinence is higher after detox, treatment, or incarceration

The high-risk window is not only "after someone leaves rehab and chooses to use." It includes several ordinary transitions:

  • After medical detox, when the body is no longer accustomed to a prior dose
  • After a residential stay, including a stay that went well
  • After incarceration or another setting where use stopped
  • After a person stops medication for opioid use disorder, or leaves treatment before a continuing-care plan is in place

NIDA also lists a past history of overdose, using alone, combining opioids with sedating medications such as benzodiazepines and alcohol, and using illicit opioids contaminated with fentanyl as risk factors, along with compromised respiratory, renal, or liver function. NIDA: Overdose prevention education for clinicians

None of those factors means that detox or residential treatment caused the overdose. The risk comes from a return to use after tolerance has fallen, often into a supply the person cannot accurately dose. Staying in treatment, including medication for opioid use disorder when it is indicated, is the protection NIDA tells clinicians to emphasize.

If someone has already returned to use, our guide on what to do after a relapse is about getting back into recovery without shame. This article is about the pharmacology that makes that return especially dangerous.

Why a guessed dose is especially dangerous in the current illicit supply

Even when someone knows what they used to take, they often cannot know what is in an illicit opioid now. In Palm Beach County, fentanyl — not heroin or prescription oxycodone — dominates fatal overdoses.

The Palm Beach County Medical Examiner's Office reported that in 2025 there were 232 accidental drug fatalities, 166 of which (71.6%) involved one or more opioid drugs. Fentanyl and its analogs, including acetyl fentanyl and fluorofentanyl, far exceeded other opiates such as heroin and oxycodone. Most opioid deaths had more than one opioid contributing; 27 opioid deaths were caused by illicit fentanyl alone. The average age of accidental drug fatality victims was 43, and the victims were predominantly men. These figures count accidental drug deaths only. Suicidal overdoses and deaths in which the manner was undetermined are not included in those graphs. Palm Beach County Medical Examiner, Annual Report 2025

Non-fatal overdoses tell a similar story. In the Florida Department of Health in Palm Beach County's 2024 Overdose Data to Action report, opioids were involved in 72.8% of analyzed cases, with fentanyl the most frequently reported. Benzodiazepines were documented in 19.7% of cases, and 55.8% of cases received naloxone. Florida DOH–Palm Beach County, 2024 OD2A non-fatal overdose report

Those local numbers do not measure overdose risk after abstinence by themselves. They do show why a "dose I used to handle" is a poor safety plan. In a supply where fentanyl and its analogs far exceed other opiates, the amount in any given pill or powder can be unknown, and more than one opioid may be present.

For a closer look at other adulterants, including xylazine, see our earlier article on xylazine and nitazenes. The point here is more specific: after a period of abstinence, even a correctly identified opioid can be too much, and an unidentified fentanyl mixture can be much too much.

Other risk multipliers: using alone, and mixing with alcohol or benzodiazepines

Tolerance is not the only variable. NIDA and the CDC both flag combining opioids with benzodiazepines or other sedating substances. The CDC lists taking benzodiazepines with opioids as an overdose risk factor. NIDA names combining prescribed medications with other opioids or with sedating medications such as benzodiazepines and alcohol. CDC: Risks and how to reduce them; NIDA: Overdose prevention education for clinicians

Using alone is another risk factor NIDA highlights, because there may be no one present to recognize an overdose and give naloxone. The signs NIDA lists include confusion, slurred speech, drowsiness, slowed or shallow breathing, blue lips or nails, or unresponsiveness.

If an overdose is suspected, NIDA's clinician education is straightforward. If the person is responsive, call 911, stay with them, and continue to provide stimulation until help arrives. If they are not responsive, or become unresponsive, administer naloxone, call 911, and wait with them. Additional doses of naloxone, or CPR, may be necessary. NIDA: Overdose prevention education for clinicians

Two adults talk quietly in a clinical lounge, with no drug paraphernalia in view, after a discussion of aftercare and naloxone.

Photo for illustrative purposes. Posed by models. Photo: MexChriss / Shutterstock.

What actually reduces overdose risk after abstinence

Fear alone is not a plan. The federal sources above point to a small set of protections that can be put in place before someone leaves detox or residential treatment.

Stay in treatment, including medication when it is indicated. NIDA tells clinicians to stress that adhering to treatment for opioid use disorder, including the use of medication, is the most effective protection against relapse and overdose. Medical detox is a first step, not the whole plan. What happens after detox is a practical guide to that next stretch of care. Medication-assisted treatment at Ambrosia is provided through the detox center; ask about medication for opioid use disorder when you call.

Make a safety plan, and revise it as circumstances change. NIDA describes safety planning as a collaborative process. One starting question is simple: "How will you keep yourself safe from an overdose?"

Keep naloxone in the home, and make sure someone else knows how to use it. NIDA recommends co-prescribing naloxone. The CDC also describes naloxone as part of reducing overdose risk. In Florida, iSaveFL can help you find naloxone nearby. A period of abstinence is exactly the wrong time to leave naloxone packed away "for later."

Do not treat a past dose as a safe dose. That is the core of lowered tolerance, and it is the sentence families should take with them on discharge day.

Aftercare is where those pieces are supposed to come together. Ambrosia's aftercare program is the continuing-care step after a more intensive level of treatment. If residential care is the right next level after detox, Ambrosia Treatment Center on Singer Island provides 24-hour structure for adult addiction treatment. Ambrosia has been open since 2007. No program can promise that overdose will not occur, which is why naloxone and a plan for the first days at home still matter after a stay goes well.

Frequently asked questions

Why is overdose risk higher after leaving detox or rehab?

Because opioid tolerance can fall during abstinence. The CDC and NIDA both identify lowered tolerance after a period without use — including during treatment or after incarceration — as an overdose risk factor. A return to a previously tolerated dose can then be enough to stop breathing.

Does tolerance go down if I have only been abstinent for a short time?

It can. Federal sources do not give a single safe number of days after which tolerance has or has not changed. The cautious assumption, even after a short period without opioids, is that a former dose may no longer be survivable.

Why can a dose I used before now cause an overdose?

The body is no longer adapted to that amount, and the illicit supply may contain fentanyl or more than one opioid at an unknown strength. In Palm Beach County in 2025, fentanyl and its analogs far exceeded other opiates in accidental opioid deaths.

Does naloxone still work if fentanyl is involved?

Naloxone is an opioid antagonist used to reverse opioid overdose, including overdoses that involve fentanyl. NIDA notes that additional doses may be necessary. Call 911 even if you have given naloxone. Naloxone does not reverse non-opioid sedatives such as xylazine; our xylazine and nitazenes article explains that distinction.

Should naloxone be in the home after residential treatment?

Yes. NIDA recommends co-prescribing naloxone and planning who will administer it and call for help. A period of abstinence is a reason to have naloxone ready, not a reason to leave it behind.

What should I do if someone is unresponsive after using?

Call 911. If you have naloxone, give it. If the person is unresponsive, NIDA advises administering naloxone, calling 911, and staying until help arrives. Additional doses or CPR may be needed. If you are not sure whether it is an overdose, treat it as one.

Getting help at Ambrosia

Medical detox is only the first step. Call Ambrosia admissions at (888) 492-1633 to plan medically supervised detox at Midwest Detox in West Palm Beach, residential treatment when it is the right level of care, and aftercare that includes overdose education and naloxone.

Admissions can verify insurance. Ambrosia is in network with most insurances. Logos do not mean every plan is in network. Coverage varies by plan, service, and location, and benefit information is an estimate, not a guarantee of payment. If a clinically needed stay or a longer stretch of aftercare is not fully covered, admissions can discuss private-pay options so that care is not cut short. You can also request a callback.

Help is available when you are ready

If you have questions about mental health or substance use treatment — for yourself or for someone you love — our admissions team can talk them through with you.